Mon, October 4, 2010
Sun, October 3, 2010
Fri, October 1, 2010
Thu, September 30, 2010
Wed, September 29, 2010
Tue, September 28, 2010
Mon, September 27, 2010
[ Mon, Sep 27th 2010 ] - Market Wire
Wellstar Announces New Website
Sun, September 26, 2010
Sat, September 25, 2010
Fri, September 24, 2010
Thu, September 23, 2010
Wed, September 22, 2010
Tue, September 21, 2010
Mon, September 20, 2010
Fri, September 17, 2010
Thu, September 16, 2010
Wed, September 15, 2010
[ Wed, Sep 15th 2010 ] - Market Wire
Qtrax Beta Available in India
Tue, September 14, 2010
Mon, September 13, 2010

ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION';S PLATINUM CHROMIUM TAXUS(


//health-fitness.news-articles.net/content/2010/ .. tific-corporation-s-platinum-chromium-taxus.html
Published in Health and Fitness on Wednesday, September 22nd 2010 at 11:50 GMT by Market Wire   Print publication without navigation


 Forward Looking Statements -------------------------- 
 --------------------- (1) Academic Research Consortium (2) The TAXUS Express and TAXUS Liberté Stent Systems are not specifically indicated for diabetic patients in the U.S. (3) Based on bench testing. Data on file with Boston Scientific. (4) The TAXUS Element Stent System will be commercialized as the ION(TM) Paclitaxel-Eluting Platinum Chromium Coronary Stent System in the U.S. 

Publication Contributing Sources